TherapeuticsMD, Inc. Gross Profit

Quick Answer

TherapeuticsMD, Inc. reported Gross Profit of $1.30 million for the year ending 2023.

  • TherapeuticsMD, Inc. showed a decrease of -98.1% in Gross Profit from 2022 to 2023.
  • This data is from TherapeuticsMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 29, 2024.
  • XBRL data for this metric is available from 2011 to 2023 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2013: $1.16 million | Q2 2013: $1.6 thousand | Q3 2013: $1.6 thousand | Q4 2013: $2.4 thousand | Q1 2014: $2.00 million | Q2 2014: $2.86 million | Q3 2014: $3.12 million | Q4 2014: $3.38 million | Q1 2015: $3.43 million | Q2 2015: $3.82 million | Q3 2015: $4.00 million | Q4 2015: $4.40 million | Q1 2016: $3.82 million | Q2 2016: $3.27 million | Q3 2016: $4.30 million | Q4 2016: $3.78 million | Q1 2017: $3.33 million | Q2 2017: $3.57 million | Q3 2017: $3.72 million | Q4 2017: $3.53 million | Q1 2018: $3.14 million | Q2 2018: $3.31 million | Q3 2018: $2.78 million | Q4 2018: $4.14 million | Q1 2019: $3.18 million | Q2 2019: $4.83 million | Q3 2019: $22.28 million | Q4 2019: $13.02 million | Q1 2020: $9.54 million | Q2 2020: $6.30 million | Q3 2020: $16.06 million | Q4 2020: $17.00 million | Q1 2021: $15.18 million | Q2 2021: $18.87 million | Q3 2021: $20.12 million | Q4 2021: $13.94 million | Q1 2022: $14.47 million | Q2 2022: $0.00 | Q3 2022: $0.00 | Q1 2023: $416.0 thousand | Q2 2023: $437.0 thousand | Q3 2023: -$53.0 thousand.
  • Over the full 13 years of available data (2011 to 2023), TherapeuticsMD, Inc.'s Gross Profit has grown by 14.1%.
  • Historical annual values: Fiscal year 2023: $1.30 million | Fiscal year 2022: $68.57 million | Fiscal year 2021: $1.17 million | Fiscal year 2020: $48.90 million | Fiscal year 2019: $43.31 million | Fiscal year 2018: $13.36 million | Fiscal year 2017: $14.14 million | Fiscal year 2016: $15.17 million | Fiscal year 2015: $15.64 million | Fiscal year 2014: $11.35 million | Fiscal year 2013: $6.82 million | Fiscal year 2012: $2.47 million | Fiscal year 2011: $1.14 million.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: